MedTrace Logo

Conservative Management in Patients Diagnosed With Grade 2 or Grade 3 CIN

NCT04115787 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 104

Last updated 2019-10-04

No results posted yet for this study

Summary

Consecutive inclusion and collection of information for all women attending the Cervical Disease Unit with an histological diagnosis of grade 2 or grade 3 CIN during the last 5 years, from January 2012 to December 2016, which meet the inclusion criteria, have voluntarily manifested pregnancy intendedness and had a minimum follow-up time of 2 years and a maximum of 7.

The aim is to evaluate whether the HSIL resolution rates (CIN 2 or CIN 3) are sufficient to support conservative management.

Conditions

  • High-Grade Squamous Intraepithelial Lesions
  • Neoplasm Regression, Spontaneous
  • Disease Progression
  • Papillomavirus Infections

Sponsors & Collaborators

  • Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-10-14
Primary Completion
2019-11-28
Completion
2019-12-28

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04115787 on ClinicalTrials.gov